Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Radius Recycling Inc (NQ: RDUS )

20.50 +0.29 (+1.43%)
Streaming Delayed Price Updated: 3:51 PM EST, Nov 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Radius Recycling Inc

< Previous 1 2 3 4 Next >
Benzinga's Top Ratings Upgrades, Downgrades For December 10, 2021
Upgrades According to JP Morgan, the prior rating for Arconic Corp (NYSE: 
Via Benzinga
10 Biggest Price Target Changes For Friday
Keybanc boosted the price target on Broadcom Inc. (NASDAQ: 
Via Benzinga
Analyst Ratings For Radius Health
Analysts have provided the following ratings for Radius Health (NASDAQ:RDUS 
Via Benzinga
52 Biggest Movers From Yesterday
Gainers Insignia Systems, Inc. (NASDAQ: ISIG) shares surged 84.1% to close at $19.11 on Wednesday. Insignia Systems recently announced the commencement of a formal process to... 
Via Benzinga
Mid-Afternoon Market Update: Nasdaq Rises 70 Points; Stitch Fix Shares Slide
Toward the end of trading Wednesday, the Dow traded down 0.08% to 35,692.63 while the NASDAQ rose 0.45% to 15,757.04. The S&P also rose, gaining 0.12% to 4,692.41. The U.S.... 
Via Benzinga
Topics Stocks
Exposures US Equities
Why Radius Health Stock Is Getting Pummeled Today
A closer look at the clinical trial results that drove the stock up in October was a little disappointing. 
Via The Motley Fool
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers Virpax Pharmaceuticals (NASDAQ:VRPX) shares increased by 26.54% to $5.12 during Wednesday's regular session. Trading volume for Virpax Pharmaceuticals's... 
Via Benzinga
Radius Health Reveals Detailed Elacestrant Data From Late-Stage Breast Cancer Trial
The Menarini Group and Radius Health Inc (NASDAQ: RDUS) have provided details on the elacestrant data from the EMERALD Phase 3 trial presented at the San... 
Via Benzinga
Mid-Day Market Update: Photronics Rises Following Upbeat Q4 Results; Radius Health Shares Slide
Midway through trading Wednesday, the Dow traded down 0.13% to 35,673.40 while the NASDAQ fell 0.10% to 15,670.88. The S&P also fell, dropping 0.11% to 4,681.64. The U.S. has... 
Via Benzinga
Topics Stocks
Exposures US Equities
35 Stocks Moving In Wednesday's Mid-Day Session
Gainers Insignia Systems, Inc. (NASDAQ: ISIG) shares jumped 79% to $18.63. Insignia Systems recently announced the commencement of a formal process to explore strategic options... 
Via Benzinga
Mid-Morning Market Update: Markets Mixed; United Natural Foods Beats Q1 Views
Following the market opening Wednesday, the Dow traded up 0.10% to 35,754.05 while the NASDAQ fell 0.09% to 15,672.72. The S&P also rose, gaining 0.06% to 4,689.49. The U.S.... 
Via Benzinga
Topics Stocks
Exposures US Equities
Radius Health Stock Stares At 52-Week Low After Disappointing Abaloparatide Transdermal Data In Osteoporosis
Radius Health Inc (NASDAQ: RDUS) posted topline data from Phase 3 wearABLe study evaluating the non-inferiority (NI) of abaloparatide transdermal system (abalo-TDS... 
Via Benzinga
What 5 Analyst Ratings Have To Say About Radius Health
Over the past 3 months, 5 analysts have published their opinion on Radius Health (NASDAQ: 
Via Benzinga
Radius Health (RDUS) Q3 2021 Earnings Call Transcript
RDUS earnings call for the period ending September 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Earnings Outlook For Radius Health
Radius Health (NASDAQ:RDUS) is set to give its latest quarterly earnings report on Monday, 2021-11-08. Here's what investors need to know before the announcement. Analysts... 
Via Benzinga
Earnings Scheduled For November 8, 2021
Companies Reporting Before The Bell • Privia Health Group (NASDAQ:PRVA) is projected to report quarterly loss at $0.11 per share on revenue of $215.14 million. •... 
Via Benzinga
48 Biggest Movers From Yesterday
Gainers Xiaobai Maimai Inc. (NASDAQ: HX) shares surged 98.4% to settle at $18.87 on Wednesday on above-average volume. The company on Tuesday disclosed the resignation of its CEO... 
Via Benzinga
Mid-Afternoon Market Update: Nasdaq Turns Lower; Sesen Bio Shares Surge
Toward the end of trading Wednesday, the Dow traded up 0.46% to 35,619.52 while the NASDAQ fell 0.19% to 15,100.51. The S&P also rose, gaining 0.28% to 4,532.23. The U.S. has... 
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers Sesen Bio (NASDAQ:SESN) stock increased by 29.2% to $1.3 during Wednesday's regular session. Trading volume for this security as of 12:30 EST is 149.3 million... 
Via Benzinga
Mid-Day Market Update: Healthcare Services Drops After Q3 Results; Radius Health Shares Jump
Midway through trading Wednesday, the Dow traded up 0.40% to 35,598.89 while the NASDAQ rose 0.15% to 15,151.71. The S&P also rose, gaining 0.37% to 4,536.47. The U.S. has the... 
Via Benzinga
Topics Stocks
Exposures US Equities
Why Radius Health Stock Is Exploding Higher Today
Positive clinical-trial results for a late-stage breast cancer treatment are pushing the stock up. 
Via The Motley Fool
32 Stocks Moving In Wednesday's Mid-Day Session
Gainers Sesen Bio, Inc. (NASDAQ: SESN) rose 34.7% to $1.36. The FDA granted Sesen Bio’s request for a Type A meeting to discuss the Chemistry, Manufacturing, and Controls (... 
Via Benzinga
Exposures Product Safety
Mid-Morning Market Update: Markets Open Higher; Verizon Posts Upbeat Earnings
Following the market opening Wednesday, the Dow traded up 0.35% to 35,580.21 while the NASDAQ rose 0.11% to 15,146.02. The S&P also rose, gaining 0.32% to 4,533.97. The U.S.... 
Via Benzinga
Topics Stocks
Exposures US Equities
Why Are Radius Health Shares Soaring Today?
The Menarini Group and Radius Health Inc (NASDAQ: RDUS) have announced topline results from the EMERALD Phase 3 study evaluating elacestrant as... 
Via Benzinga
46 Biggest Movers From Yesterday
Gainers Protagonist Therapeutics, Inc. (NASDAQ: PTGX) shares jumped 93.9% to close at $35.36 on Monday. The FDA removed the full clinical hold on Protagonist Therapeutics’... 
Via Benzinga
Exposures Product Safety
3 Stocks Insiders Are Buying
When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go... 
Via Benzinga
3 Stocks Insiders Are Buying
When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go... 
Via Benzinga
Radius Health Earnings Perspective: Return On Capital Employed
According to Benzinga Pro data, during Q2, Radius Health (NASDAQ:RDUS) posted sales of $51.80 million. Earnings were up 11.28%, but Radius Health still reported an overall loss of... 
Via Benzinga
Radius Health (RDUS) Q2 2021 Earnings Call Transcript
RDUS earnings call for the period ending June 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
The Daily Biotech Pulse: Gemini Sinks On Data, Amgen's Migraine Drug Approved In Japan, Liver Congress Gets Underway
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 22) AngioDynamics, Inc. (NASDAQ... 
Via Benzinga
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.